FCN2 and sarcoidosis: Patients of the sarcoidosis group had significantly higher MBL-, ficolin-2 and ficolin-3 BALF levels compared to the controls (Table 2 and Figure 2, MBL, median 66.8 vs. 24.6 ng/ml, p = 0.02; ficolin-2 140 vs. 58.8 ng/ml, p = 0.01, ficolin-3 2523 vs. 1180 ng/ml, p = 0.02).